These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9428915)
1. Radiation therapy for stage I primary orbital non-Hodgkin's lymphomas. Erkal HS; Serin M; Sak SD; Cakmak A Tumori; 1997; 83(5):822-5. PubMed ID: 9428915 [TBL] [Abstract][Full Text] [Related]
2. Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment. Pelloski CE; Wilder RB; Ha CS; Hess MA; Cabanillas FF; Cox JD Radiother Oncol; 2001 May; 59(2):145-51. PubMed ID: 11325442 [TBL] [Abstract][Full Text] [Related]
3. Treatment and prognosis of orbital non-Hodgkin's lymphomas. Platanias LC; Putterman AM; Vijayakumar S; Recant W; Weichselbaum RR; Bitran JD Am J Clin Oncol; 1992 Feb; 15(1):79-83. PubMed ID: 1372464 [TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin's lymphoma of the ocular adnexa. Sasai K; Yamabe H; Dodo Y; Kashii S; Nagata Y; Hiraoka M Acta Oncol; 2001; 40(4):485-90. PubMed ID: 11504308 [TBL] [Abstract][Full Text] [Related]
6. Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy. Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):17-22. PubMed ID: 11163493 [TBL] [Abstract][Full Text] [Related]
7. Radiation therapy for primary orbital lymphoma. Chao CK; Lin HS; Devineni VR; Smith M Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):929-34. PubMed ID: 7860408 [TBL] [Abstract][Full Text] [Related]
8. Orbital and adnexal involvement in systemic non-Hodgkin's lymphoma. Bairey O; Kremer I; Rakowsky E; Hadar H; Shaklai M Cancer; 1994 May; 73(9):2395-9. PubMed ID: 8168043 [TBL] [Abstract][Full Text] [Related]
9. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies]. Hoederath A; Sack H; Stuschke M; Lampka E Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402 [TBL] [Abstract][Full Text] [Related]
10. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012 [TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas. Esik O; Ikeda H; Mukai K; Kaneko A Radiother Oncol; 1996 Jan; 38(1):13-8. PubMed ID: 8850421 [TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy. Krol AD; Berenschot HW; Doekharan D; Henzen-Logmans S; van der Holt B; van 't Veer MB Radiother Oncol; 2001 Mar; 58(3):251-5. PubMed ID: 11230885 [TBL] [Abstract][Full Text] [Related]
13. Stage IA non-Hodgkin's lymphoma of the Waldeyer's ring. Limited chemotherapy and radiation therapy versus radiation therapy alone. Uematsu M; Kondo M; Hiramatsu H; Ikeda Y; Mikata S; Katayama M; Ito H; Kusano S; Kubo A Acta Oncol; 1993; 32(6):675-8. PubMed ID: 8260187 [TBL] [Abstract][Full Text] [Related]
14. Indolent stage IE non-Hodgkin's lymphoma of the orbit: results after primary radiotherapy. Bischof M; Zierhut D; Neuhof D; Karagiozidis M; Treiber M; Roeder F; Debus J; Krempien R Ophthalmologica; 2007; 221(5):348-52. PubMed ID: 17728558 [TBL] [Abstract][Full Text] [Related]
15. Treatment Outcomes of Low-grade Lymphoma of the Orbit. Holloway CL; Pickles T; Croteau NS; Wai ES Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):e298-e304. PubMed ID: 35210133 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study. Yahalom J; Varsos G; Fuks Z; Myers J; Clarkson BD; Straus DJ Cancer; 1993 Apr; 71(7):2342-50. PubMed ID: 8453557 [TBL] [Abstract][Full Text] [Related]
17. Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group). Economopoulos T; Fountzilas G; Kostourou A; Daniilidis J; Pavlidis N; Andreopoulou H; Nicolaou A; Papageorgiou E; Mellou S; Dervenoulas J; Stathakis N Anticancer Res; 1998; 18(6B):4655-60. PubMed ID: 9891536 [TBL] [Abstract][Full Text] [Related]
18. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Plosker GL; Figgitt DP Drugs; 2003; 63(8):803-43. PubMed ID: 12662126 [TBL] [Abstract][Full Text] [Related]